Atlas Trials

Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Clinical trial NCT00563459 · TERMINATED

Trial details

NCT number
NCT00563459
Sponsor
SK Life Science, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
EpilepsySeizures
Start date
2007-11-01
Primary completion
2010-04-01
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.